Facet Solutions Inc. finished compiling two-year data from a Phase III clinical trial of its Acadia spinal implant, saying the patients experienced less leg and back pain and improved mobility two years after the procedure.
The Hopkinton, Mass.-based company also drummed up $2.1 million in an offering of debt, options, warrants or other securities to a group of 43 investors, according to a filing with the federal Securities & Exchange Commission.